Biotech · Private company · Seattle, WA, US

Curi Bio Inc

Track this companyFree. Adds Curi Bio Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

A cross-species preclinical platform to enhance the translation of new medicinesFiscal year 2025 · $1.1MNIH RePORTER 5R44TR004557-03 · fetched Nov 12, 2026
High-Throughput NMJ Assay for Botox Potency ScreeningFiscal year 2025 · $901.2KNIH RePORTER 5U44TR004795-03 · fetched Nov 12, 2026
A cross-species preclinical platform to enhance the translation of new medicinesFiscal year 2024 · $832.4KNIH RePORTER 4R44TR004557-02 · fetched Nov 12, 2026
High-Throughput NMJ Assay for Botox Potency ScreeningFiscal year 2024 · $910KNIH RePORTER 4U44TR004795-02 · fetched Nov 12, 2026